Form 4: Akero Therapeutics CFO William White Executes Stock Option and Sells Shares
SEC Form 4 Filing
William Richard White, CFO of Akero Therapeutics, exercised stock options and sold shares on July 16, 2024, according to a Form 4 filing with the SEC.
Summary
- On July 16, 2024, William Richard White, the Chief Financial Officer of Akero Therapeutics, exercised stock options to acquire 29,803 shares of common stock at a price of $7.009 per share.
- Simultaneously, White sold 29,803 shares at $28.045 and 5,008 shares at $28.045 in multiple transactions with prices ranging from $28.000 to $28.125.
- Following these transactions, White directly owns 41,791 shares of Akero Therapeutics common stock.
- White also holds options to purchase 194,526 shares of common stock, which are vested and currently exercisable.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine executive stock transactions under a pre-arranged plan. There's no indication of unusual activity or concern.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often used as part of compensation packages and personal financial planning. The use of a 10b5-1 trading plan suggests a pre-arranged strategy to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| 03/13/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 07/16/2024 | Date of stock option exercise and share sales |
| 04/04/2029 | Expiration date of stock options |
| 07/18/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.